Islet Holdings, Inc. (ISHI)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Islet Holdings, Inc. (ISHI) trades at $0.00. Islet Holdings, Inc. focuses on skincare products, offering a range of solutions for various skin types and concerns. The company also distributes skincare products of other brands through its online platform. Market cap: $5, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for ISHI: ISHI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ISHI against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ISHI: 1/1 perspectives are bearish.
How is this calculated? →Islet Holdings, Inc. (ISHI) Healthcare & Pipeline Overview
Islet Holdings, Inc. operates in the skincare sector, providing a range of products from acne treatments to anti-aging solutions, alongside distributing other brands' skincare lines online. The company caters to a diverse customer base seeking specialized skincare options in a competitive market.
What Is the Investment Thesis for ISHI?
Islet Holdings, Inc. presents a high-risk, high-reward investment profile. The company's negative profit margin of -112.1% and ROE of -2168.2% indicate significant financial challenges. However, its gross margin of 57.6% suggests potential profitability if operational efficiencies improve. Growth catalysts include expanding its online presence and strategic partnerships to broaden product distribution. The company's beta of 1.24 indicates higher volatility than the market. Investors should closely monitor the company's ability to manage costs and increase revenue to achieve sustainable profitability. The absence of dividends further underscores the speculative nature of this investment.
Based on FMP financials and quantitative analysis
ISHI Key Highlights
- Market Cap of 5 reflects the company's small size and limited investor interest.
- Gross Margin of 57.6% indicates a strong potential for profitability if operational costs are managed effectively.
- Profit Margin of -112.1% highlights significant financial challenges and the need for improved cost management.
- ROE of -2168.2% demonstrates poor return on equity, indicating inefficient use of shareholder investments.
- Beta of 1.24 suggests the stock is more volatile than the market average.
Who Are ISHI's Competitors?
ISHI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ATAI Atai Beckley NV is a clinical-stage biopharmaceutical company focused on developing treatments for mental health disorders. The company | $4.88 | -5.97% | $1.80B | 68 |
| MEDS TRxADE HEALTH, Inc. | $7.59 | +4.55% | $13.28M | 63 |
| ONC BeOne Medicines Ltd. | $309.46 | +3.97% | $33.07B | 61 |
| NEUP Neuphoria Therapeutics Inc. | $3.44 | +1.78% | $18.59M | 60 |
| YI 111, Inc. | $4.13 | -0.12% | $36.04M | 44 |
| ALBHF Alibaba Health Information Technology Limited | $0.42 | +2.44% | $6.77B | 45 |
| WBA Walgreens Boots Alliance operates as a pharmacy-led health and beauty retail company with a global presence. The company | $11.98 | +0.50% | $10.37B | 45 |
| IPXL Impax Laboratories, Inc. | $18.30 | +0.55% | 46 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ISHI's Key Strengths?
- Diverse product range.
- Established online presence.
- Distribution of other brands' products.
- Long operating history.
What Are ISHI's Weaknesses?
- Small market capitalization.
- Negative profit margin.
- High ROE.
- Limited brand recognition.
What Could Drive ISHI Stock Higher?
- Potential strategic partnerships to expand distribution channels.
- Continued focus on online marketing and e-commerce growth.
- Development of new skincare products to meet evolving consumer demands.
What Are the Key Risks for ISHI?
- Intense competition in the skincare market could limit growth.
- Negative profit margin and ROE raise concerns about financial sustainability.
- Limited liquidity due to OTC Other listing.
- Dependence on online sales makes the company vulnerable to changes in e-commerce trends.
- Lack of regulatory oversight increases the risk of fraud or mismanagement.
What Are the Growth Opportunities for ISHI?
- Expand Online Presence: Islet Holdings can significantly increase its revenue by enhancing its online platform and digital marketing efforts. The e-commerce skincare market is experiencing rapid growth, with projections estimating a market size of $174.4 billion in 2026. By optimizing its website, improving SEO, and leveraging social media marketing, Islet Holdings can attract a larger customer base and drive online sales. Timeline: Within the next 1-2 years.
- Strategic Partnerships: Collaborating with established skincare brands and retailers can provide Islet Holdings with access to new markets and distribution channels. Forming partnerships with larger companies can also enhance the company's credibility and brand recognition. The global skincare market is projected to reach $183.03 billion in 2027, creating ample opportunities for strategic alliances. Timeline: Within the next 1-3 years.
- Product Innovation: Developing new and innovative skincare products can attract new customers and retain existing ones. Focusing on emerging trends such as personalized skincare and sustainable ingredients can differentiate Islet Holdings from its competitors. The market for personalized skincare is expected to grow significantly in the coming years, driven by advancements in technology and consumer demand for customized solutions. Timeline: Ongoing.
- Geographic Expansion: Expanding into new geographic markets can increase Islet Holdings' revenue and customer base. Targeting regions with a growing demand for skincare products, such as Asia-Pacific, can provide significant growth opportunities. The Asia-Pacific skincare market is projected to be the largest globally, driven by increasing disposable incomes and a growing awareness of skincare products. Timeline: Within the next 3-5 years.
- Subscription Model: Implementing a subscription-based service can provide Islet Holdings with a recurring revenue stream and improve customer retention. Offering customized skincare routines and convenient delivery options can attract customers seeking hassle-free skincare solutions. The subscription e-commerce market is experiencing rapid growth, with projections estimating a market size of $478.2 billion in 2025. Timeline: Within the next 1-2 years.
What Opportunities Does ISHI Have?
- Expand online marketing efforts.
- Form strategic partnerships.
- Develop new and innovative products.
- Expand into new geographic markets.
What Threats Does ISHI Face?
- Intense competition in the skincare market.
- Changing consumer preferences.
- Economic downturns.
- Regulatory changes.
What Are ISHI's Competitive Advantages?
- Established brand presence since 1984.
- Diverse product range.
- Online distribution channel.
What Does ISHI Do?
Islet Holdings, Inc., originally incorporated in 1984 as Biozhem Cosmeceuticals, rebranded in May 2009 to reflect its evolving business strategy. Based in Grass Valley, California, the company focuses on developing and distributing skincare products in the United States. Their product line includes solutions for acne-prone skin, anti-aging, and sensitive skin, as well as moisturizers, toners, cleansers, and specialized botanical treatments. The company also distributes skincare products from other brands, expanding its offerings through its online platform and customer service center in Arizona. Islet Holdings, Inc. aims to provide a comprehensive range of skincare options to meet diverse customer needs, positioning itself as a versatile player in the competitive skincare market. Despite its long history, the company remains relatively small, with a limited number of employees.
What Products and Services Does ISHI Offer?
- Offers skincare products for acne-prone skin.
- Provides anti-aging skincare solutions.
- Develops products with berridroxies.
- Creates botanical skincare products.
- Offers eye treatment products.
- Provides moisturizers and creams.
- Offers products for sensitive skin.
- Distributes skincare products from other brands.
How Does ISHI Make Money?
- Develops and sells its own line of skincare products.
- Distributes skincare products from other brands.
- Generates revenue through online sales.
What Industry Does ISHI Operate In?
Islet Holdings, Inc. operates within the competitive skincare market, which is characterized by evolving consumer preferences and a constant influx of new products. The industry is driven by trends such as anti-aging solutions, natural ingredients, and personalized skincare. Competitors range from large multinational corporations to smaller niche brands. Islet Holdings differentiates itself by offering a diverse product range and distributing other brands' products. The company faces challenges in marketing, distribution, and maintaining a competitive edge in a rapidly changing market.
Who Are ISHI's Key Customers?
- Individuals with acne-prone skin.
- Individuals seeking anti-aging solutions.
- Individuals with sensitive skin.
- Customers seeking general skincare products.
Company Profile
Islet Holdings, Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Grass Valley, US. The company is led by CEO J. Michael Heil. ISHI has traded publicly since 2012.
ISHI Financials
Bull Case vs Bear Case
Bull Case
- Diverse product range.
- Established online presence.
- Distribution of other brands' products.
- Long operating history.
Bear Case
- Small market capitalization.
- Negative profit margin.
- High ROE.
- Limited brand recognition.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
ISHI Latest News
-
Former ECB Rate-Setter Muller Reports for Duty as Volunteer Cop
Bloomberg · Jun 13, 2026
ISHI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ISHI.
Price Targets
Wall Street price target analysis for ISHI.
ISHI MoonshotScore
What does this score mean?
The MoonshotScore rates ISHI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: J. Michael Heil
CEO
J. Michael Heil serves as the CEO of Islet Holdings, Inc. His leadership is pivotal in guiding the company's strategic direction and operational execution. With a focus on the skincare industry, Heil is responsible for overseeing the development, distribution, and marketing of the company's product line. His background includes experience in managing small teams and navigating the challenges of a competitive market. He is based in Grass Valley, California, where the company is headquartered.
Track Record: Under J. Michael Heil's leadership, Islet Holdings, Inc. has focused on maintaining its presence in the skincare market and expanding its online distribution channels. Key achievements include sustaining a diverse product range and navigating the competitive landscape. He has also overseen the company's efforts to distribute skincare products from other brands, enhancing its offerings to customers.
ISHI OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Islet Holdings, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk due to the potential for less transparency and greater price volatility.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to low trading volume.
- Lack of regulatory oversight compared to major exchanges.
- Potential for price manipulation.
- Information asymmetry due to limited disclosure.
- Higher risk of fraud or mismanagement.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's revenue and profitability trends.
- Check for any legal or regulatory issues.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Company has been in operation since 1984.
- Offers a range of skincare products.
- Maintains an online presence.
- Has a customer service center in Arizona.
Islet Holdings, Inc. Healthcare Stock: Key Questions Answered
What does Islet Holdings, Inc. do?
Islet Holdings, Inc. is a skincare company that develops and distributes a range of skincare products, including solutions for acne-prone skin, anti-aging, and sensitive skin. It also distributes products from other brands. The company primarily operates through its online platform, offering customers a convenient way to purchase skincare products. Islet Holdings aims to provide a comprehensive selection of skincare options to meet diverse customer needs in the competitive skincare market. The company was founded in 1984 and is based in Grass Valley, California.
What do analysts say about ISHI stock?
There is currently no available analyst coverage for ISHI stock. Given its OTC Other listing and small market capitalization, the company is unlikely to be actively tracked by major financial analysts. Investors should rely on their own due diligence and research to assess the company's potential and risks. Key valuation metrics to consider include revenue growth, gross margin, and profitability trends. The company's growth prospects depend on its ability to expand its online presence, form strategic partnerships, and develop innovative products. However, its negative profit margin and ROE raise concerns about its financial sustainability.
What are the main risks for ISHI?
Islet Holdings, Inc. faces several risks, including intense competition in the skincare market, which could limit its ability to gain market share and grow revenue. The company's negative profit margin and ROE raise concerns about its financial sustainability and ability to generate returns for investors. Its OTC Other listing exposes it to limited liquidity and regulatory oversight, increasing the risk of price volatility and fraud. Furthermore, the company's dependence on online sales makes it vulnerable to changes in e-commerce trends and consumer preferences. Investors should carefully consider these risks before investing in ISHI.
What are the key factors to evaluate for ISHI?
Evaluate ISHI on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does ISHI data refresh on this page?
ISHI prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ISHI's recent stock price performance?
Islet Holdings, Inc. (ISHI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product range. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ISHI overvalued or undervalued right now?
Valuing Islet Holdings, Inc. (ISHI) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying ISHI?
Before investing in Islet Holdings, Inc. (ISHI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available for this OTC-listed company.
- Financial data may not be fully up-to-date.